Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PROC”

72 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 72 results

Large-scale testing (Phase 3)Looking for participantsNCT07604766
What this trial is testing

An Extension Study to Assess the Efficacy of Rina-S Compared to Treatment of Investigator's Choice in Participants With Platinum Resistant Ovarian Cancer in China

Who this might be right for
Platinum-resistant Ovarian Cancer
Genmab 82
Not applicableStudy completedNCT03250728
What this trial is testing

Role of the Endothelium in Stroke-like Episode Among CDG Patients

Who this might be right for
Congenital Disorders of Glycosylation
Assistance Publique - Hôpitaux de Paris 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT06334432
What this trial is testing

Safety and Efficacy Study of NUV-1511 in Adult Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorHER2-negative Breast CancerMetastatic Castration-resistant Prostate Cancer (mCRPC)+2 more
Nuvation Bio Inc. 466
Testing effectiveness (Phase 2)Looking for participantsNCT05824975
What this trial is testing

Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorSoft Tissue Sarcoma (STS)+6 more
GI Innovation, Inc. 358
Not applicableStudy completedNCT05513768
What this trial is testing

PRETERM DELİVERY and MYOCINE BINDING PROTEIN C LEVELs

Who this might be right for
Preterm
Gaziosmanpasa Research and Education Hospital 90
Testing effectiveness (Phase 2)Study completedNCT04984889
What this trial is testing

TAK-662 for Japanese Patients With Congenital Protein C Deficiency

Who this might be right for
Congenital Protein C Deficiency
Takeda 5
Large-scale testing (Phase 3)Ended earlyNCT05092360
What this trial is testing

Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7)

Who this might be right for
Platinum-resistant Ovarian CancerFallopian Tube CancerPrimary Peritoneal Cancer
Mural Oncology, Inc 456
Not applicableUnknownNCT03625726
What this trial is testing

Rôle of the Soluble Endothelial Protein C Receptor in Cirrhosis-associated Hypercoagulability State (EXERCISE)

Who this might be right for
Cirrhosis
University Hospital, Clermont-Ferrand 300
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07741630
What this trial is testing

Mirvetuximab Soravtansine Combined With Suvemcitug in Platinum-Resistant Recurrent Ovarian Cancer

Who this might be right for
PROC
Peking University Third Hospital 20
Not applicableStudy completedNCT01806428
What this trial is testing

Activated Protein C and Microcirculation

Who this might be right for
Severe SepsisSeptic Shock
Università Politecnica delle Marche 22
Early research (Phase 1)Looking for participantsNCT07444814
What this trial is testing

Study Evaluating the Safety and Efficacy of HWK-007, a PTK7-directed Antibody Drug Conjugate in Participants With Advanced Solid Tumors

Who this might be right for
Endometrial CancerOvarian CancerOvarian Cancer Metastatic+4 more
Whitehawk Therapeutics, Inc. 226
Not applicableStudy completedNCT06482866
What this trial is testing

Synechie Afrer Rhinosug. Proc. 2024

Who this might be right for
Complication of Surgical Procedure
Mateusz Jan Stępiński 243
Not applicableStudy completedNCT02833194
What this trial is testing

Assessment of the Prevalence of Major Psychiatric Disorders in a Cohort of Women With Clinical Criteria Corresponding to Pure, Abortive-form, Obstetrical, Antiphospholipid Syndrome

Who this might be right for
Antiphospholipid SyndromeFactor V Leiden Thrombophilia
Centre Hospitalier Universitaire de Nīmes 1,592
Testing effectiveness (Phase 2)Study completedNCT00386425
What this trial is testing

Evaluate Protein C Levels in Severe Sepsis Patients on Drotrecogin Alfa (Activated)

Who this might be right for
Severe Sepsis
Eli Lilly and Company 486
Not applicableStudy completedNCT00943267
What this trial is testing

Effect of Intrapulmonary Recombinant Human Activated Protein C (APC) on Coagulation and Inflammation After Lipopolysaccharide (LPS)

Who this might be right for
PneumoniaLipopolysaccharides
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 52
Not applicableUnknownNCT04180657
What this trial is testing

Ghrelin Levels in Patients With Protein C Deficiency

Who this might be right for
Protein C Deficiency
University of Aarhus 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06600841
What this trial is testing

Adebrelimab Combined with Non-platinum Chemotherapy and Fuzuloparib in Recurrent Platinum-resistant Ovarian Cancer

Who this might be right for
Platinum-resistant Ovarian Cancer (PROC)Immunotherapy
Fujian Cancer Hospital 37
Testing effectiveness (Phase 2)Study completedNCT05613088
What this trial is testing

MORAb-202 Versus Investigator's Choice Chemotherapy in Female Participants With Platinum-resistant High-grade Serous (HGS) Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Who this might be right for
Neoplasms, Ovarian
Bristol-Myers Squibb 106
Not applicableStudy completedNCT00883597
What this trial is testing

Sidestream Dark-Field (SDF) Imaging of the Intestinal Microcirculation

Who this might be right for
Sepsis
Nova Scotia Health Authority 36
Testing effectiveness (Phase 2)Looking for participantsNCT05579366
What this trial is testing

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Who this might be right for
High Grade Epithelial Ovarian CancerHigh Grade Serous Ovarian CancerPrimary Peritoneal Carcinoma+12 more
Genmab 884
Next Page